A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia

Nat Commun. 2022 Aug 9;13(1):4380. doi: 10.1038/s41467-022-31860-w.

Abstract

Emerging diseases caused by coronaviruses of likely bat origin (e.g., SARS, MERS, SADS, COVID-19) have disrupted global health and economies for two decades. Evidence suggests that some bat SARS-related coronaviruses (SARSr-CoVs) could infect people directly, and that their spillover is more frequent than previously recognized. Each zoonotic spillover of a novel virus represents an opportunity for evolutionary adaptation and further spread; therefore, quantifying the extent of this spillover may help target prevention programs. We derive current range distributions for known bat SARSr-CoV hosts and quantify their overlap with human populations. We then use probabilistic risk assessment and data on human-bat contact, human viral seroprevalence, and antibody duration to estimate that a median of 66,280 people (95% CI: 65,351-67,131) are infected with SARSr-CoVs annually in Southeast Asia. These data on the geography and scale of spillover can be used to target surveillance and prevention programs for potential future bat-CoV emergence.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asia, Southeastern / epidemiology
  • COVID-19*
  • Chiroptera*
  • Evolution, Molecular
  • Humans
  • Phylogeny
  • Seroepidemiologic Studies
  • Severe acute respiratory syndrome-related coronavirus*